Abstract
Interleukin (IL) 12 is a heterodimeric proinflammatory cytokine that is produced by activated antigen-presenting cells, such as monocytes/macrophages and dendritic cells. It induces the production of interferon (IFN) γ and forms a link between innate resistance and adaptive immunity.1-3 Interleukin 23 is a newly identified cytokine that shares the p40 subunit with IL-12 but is distinguished from the latter by the IL-12p35–related subunit p19. Interleukin 23 does differ from IL-12 in the T-cell subsets that it targets4: whereas IL-12 acts on naive T lymphocytes, IL-23 preferentially acts on memory T cells.5-7 Interleukin 12, critical in determining the differentiation and generation of T helper-1 cells, was thought to be essential for T-cell–dependent immune and inflammatory responses8-10 and was reported to be required for the induction of experimental autoimmune encephalomyelitis (EAE), an animal model of autoimmune-mediated inflammation of the central nervous system.11-13 However, recent evidence indicates that IL-12 is not essential in the development of EAE or a number of other inflammatory disorders.14-16 Perplexity as to the role of IL-12 in inflammation arose because the previously unknown cytokine IL-23 contains the same p40 subunit as IL-12.16,17